HY001N cell injection

BIOLOGICAL2 trials

Sponsors

Juventas Cell Therapy Ltd.

Conditions

Autoimmune Hemolytic Anemia (AIHA)Neurological Autoimmune Diseases

Early Phase 1

A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

Not yet recruitingNCT07265206

Juventas Cell Therapy Ltd.Neurological Autoimmune Diseases

Start: 2025-12-30End: 2028-12-30Target: 15Updated: 2025-12-04

Phase 1

HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.

RecruitingNCT07748533

Juventas Cell Therapy Ltd.Autoimmune Hemolytic Anemia (AIHA)

Start: 2026-07-02End: 2028-10-01Target: 9Updated: 2026-08-05